Eicosapentaenoic acid ethyl ester (AMR 101) therapy in patients with very high triglyceride levels (from the Multi-center, Placebo-controlled, Randomized, Double-Blind...
Bays HE, Ballantyne CM, Kastelein JJ, Isaacsohn JL, Braeckman RA, Soni PN, Am J Cardiol, 1/1/2011Carotid atherosclerosis progression in familial hypercholesterolemia patients: pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies
Vergeer M, Zhou R, Bots ML, Duivenvoorden R, Koglin J, Ahdim F, Mitchel YB, Huigen R, Sapre A, de Groot E, Sijbrands EJ, Pasternak RC, Gagne C, Marais AD, Ballantyne C..., Circ Cardiovasc Imaging, 1/1/2010Risk reduction and tolerabi lity of fluvastatin in patients with the metabolic syndrome: a pooled analysis of thirty clinical trials
Winkler K, Ablethauser CB, Gimpelewicz C, Bortolini M, Isaacsohn JL, Clin. Ther., 1/20/2007Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age
Bruckert E, Verpilleux MP, Dejager S, Isaacsohn J, Am J Cardiol, 1/16/2005Effects of colesevelam HC1 on sterol and bile acid excretion in patients with type lla hypercholesterolemia
Donovan JM, Von Bergmann K, Setchell KD, Isaacsohn J, Pappu AS, Illingworth DR, Olson T, Burke SK, Dig Dis Sci, 1/1/2005Effects of simvastatin, an HMG-C0A reductase inhibitor, in patients with hypertriglyceridemia
Isaacsohn J, Hunninghake D, Schrott H, Dujovne CA, Knopp R, Weiss SR, Bays H, Crouse III JR, Davidson MH, Keilson LM, McKenney J, Korenman SG, Dobs AS, Stein E, Krauss..., Clin Cardiol, 1/1/2003Comparison of treatment with fluvastatin extended-release 80-mg tablets and immediate-release 40-mg capsules in patients with primary hypercholesterolemia
Isaacsohn JL, LaSalle J, Chao G, Gonasun L, Clinical Therapeutics, 1/1/2003Addressing a treatment gap: rationale for increasing the start dose of simvastatin in hypercholesterolemic patients
Isaacsohn J, Tobert JA, Johnson-Levonas AO, Landsman P, Clinical Drug Investigation, 1/1/2002The Long Term Efficacy and Safety of Cerivastatin 08 mg in Patients with Primary Hypercholesterolemia
Isaacsohn J, Insull W, Stein E, Kwiterovich P, Ma P, Brazg R, Dujovne C, Shan M, Shugrue-Crowley E, Ripa S, Tota R, for the Cerivastatin Study Group, Clinical Cardiol, 1/1/2001Influence of gender on the pharmacokinetics, safety and tolerability of cerivastatin in healthy adults
Isaacsohn J, Zinny M, Mazzu A, Lettieri J, Heller AH, Euro J Clin Pharmacol, 1/1/2001An Evaluation of the Potential Interactions between Cerivastatin and Erythromycin or Itraconazole in Hypercholesterolemic Patients
Isaacsohn J, Kelly E, Mazzu A, Lettieri J, Bradley D, Sundaresan P, J Clin Pharmacol, 1/1/2000For the Simvastatin Atorvastatin HDL Study Group Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-...
Kastelein JJ, Isaacsohn JL, Ose L, Hunninghake DB, Frohlich J, Davidson MH, Habib R, Dujovne CA, Crouse JR, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Am J Cardiol, 1/1/2000Efficacy and safety of cerivastatin 08 mg in patients with hypercholesterolemia: the pivotal placebo-controlled clinical trial
Insull W, Isaacsohn J, Kwiterovich P, Ra P, Brazg R, Dujovne C, Shan M, Shugrue-Crowley E, Ripa S, Tota R for the Cerivastatin Study Group, J Int Med Res, 1/1/2000Efficacy and Safety of Lovastatin in Adolescent Males with Heterozygous Familial Hypercholesterolemia
Stein EA, Illingworth DR, Kwiterovich PO, Liacouras CA, Siimes MA, Jacobson MS, Brewster TG, Hopkins P, Davidson M, Graham K, Arensman F, Knopp RH, Dujove C, Williams ..., JAMA, 1/1/1999Pharmacodynamics, Safety, Tolerability and Pharmcokinetics of the 08 mg dose of Cerivastatin in Patients with Primary Hypercholesterolemia
Stein EA, Isaacsohn J, Stolz R, Mazzu A, Liu MC, Lane C, Heller AH, Am J Cardiol, 1/1/1999Colesevelam hydrochoride (cholestagel): a new, potent bile acid sequestrant associated with a low incidence of gastrointestinal side effects
Davidson MH, Dillon MA, Gordon B, Jones P, Samuels J, Weiss S, Isaacsohn J, Toth P, Burke SK, Arch Intern Med, 1/1/1999Long-term Effects of Low-density Lipoprotein Apheresis, using an Automated Dextran Sulfate Cellulose Absorption System Liposorber Study
Gordon BR, Kelsey SF, Dau PC, Gotto AM, Graham K, Illingworth DR, Isaacsohn JL, Jones PH, Leitman SF, Saal SD, Stein EA, Stern TN, Troendle A, Zweiner RJ, for the Lipo..., Am J Cardiol, 1/1/1998Garlic-Powder and Plasma Lipids and Lipoproproteins; A Multi-Center, Randomized Trial
Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, Black HR, Arch Int Med, 1/1/1998Effect of Cilostazol on Walking Distances in Patients with Intermittent Claudication Caused by Peripheral Vascular Disease
Money SR, Herd JA, Isaacsohn JL, Davidson M, Cutler B, Heckman J, Forbes WP, J Vase. Surg., 1/1/1998Atorvastatin, a New HMG-CoA Reductase Inhibitor, Does not Affect Adrenocortrical Hormones in Patients with Hypercholesterolemia
Isaacsohn J, Bakker-Arkema B, Fayyad R, Whitcomb R, Black D, J Cardiovasc Pharmacol Therapeut, 1/1/1997A Randomized Multicenter Trial Comparing the Efficacy of Simvastatin and Fluvastatin
Illlingworth Dr, Stein EA, Knopp RH, Hunninghake DB, Davidson MH, Dujovne CA, Miller VT, Tobert JA, Laskarzewski PM, Isaacsohn JL, Bacon BS, Tate AC, J Cardiovasc Pharmacol Therapeut, 1/1/1996Efficacy and Safety of a New HMG-CoA Reductase Inhibitor in Patients with Hypertriglyceridemia
Bakker-Arkema RG, Davidson MH, Goldstein RJ, Davignon J, Isaacsohn JL, Weiss SR, Kielson LM, Brown WV, Miller VT, Shurzinske LJ, Black DM, JAMA, 1/1/1996The Efficacy and Tolerabiiity of Low Dose Simvastatin and Niacin, Alone and in Combination, in Patients with Combined Hyperlipidemia: A Prospective Trial
Stein EA, Davidson MH, Dujovne CA, Hunninghake DB, Goldberg RB, Illingworth DR, Knopp RH, Miller VT, Frost P, Isaacsohn JL, Mitchel YB, Melino MR, Shapiro DD, Tobert JA, J. Cardiovasc Pharmacol Therapeut, 1/1/1996Coronary Heart Disease Risk Factors in Men and Women aged 60 and older: Findings from the Systolic Hypertension in the Elderly Program
Frost PH, Davis BR, Burlando AJ, Curb JD, Guthrie GP, Isaacsohn JL, Wassertheil-Smoller S, Wilson AC, Stamler J; for the Systolic Hypertension in the Elderly Research ..., Circulation, 1/1/1996Treatment of Severe and/or Drug Resistant Hyperlipidemia
Stein EA, Isaacsohn JL, Exp. Opin. Invest. Drugs., 1/1/1996- Join now to see all
University of Cape Town Faculty of MedicineClass of 1977
OH State Medical License 1991 - 2024
